|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3713 USD | +0.76% |
|
+3.43% | -72.29% |
| 08/06 | Soligenix Applies for Vaccine Development Funding for Bundibugyo Ebola Vaccine | CI |
| 29/05 | Soligenix - increases maximum offering under sales agreement by $2.96 million | RE |
| Market Cap | 55.04L 48.34L 44.96L 41.26L 77.52L 53Cr 78.71L 5.34Cr 2.09Cr 26Cr 2.07Cr 2.02Cr 90Cr | P/E 2026 * |
-0.41x | P/E 2027 * | -0.55x |
|---|---|---|---|---|---|
| Enterprise Value | 55.04L 48.34L 44.96L 41.26L 77.52L 53Cr 78.71L 5.34Cr 2.09Cr 26Cr 2.07Cr 2.02Cr 90Cr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
93.26% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.76% | ||
| 1 week | +3.43% | ||
| Current month | -6.24% | ||
| 1 month | -9.44% | ||
| 3 months | -73.29% | ||
| 6 months | -71.22% | ||
| Current year | -72.29% |
| 1 week | 0.35 |  | 0.38 |
| 1 month | 0.35 | | 0.41 |
| Current year | 0.28 | | 1.49 |
| 1 year | 0.28 | | 6.23 |
| 3 years | 0.28 | | 32 |
| 5 years | 0.28 | | 295.2 |
| 10 years | 0.28 | | 2,040 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 59 | 01/08/2006 | |
Jonathan Guarino
DFI | Director of Finance/CFO | 53 | 11/09/2019 |
| Chief Tech/Sci/R&D Officer | - | 11/06/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 59 | 08/10/2009 | |
Gregg Lapointe
BRD | Director/Board Member | 67 | 01/03/2009 |
Robert Rubin
BRD | Director/Board Member | 80 | 01/10/2009 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/12/25 | Free | Chief Technology Officer | 1,00,000 | 0.9915% | ||
| 11/12/25 | Free | Chief Financial Officer | 1,00,000 | 0.9915% | ||
| 11/12/25 | Free | Chief Executive Officer | 2,00,000 | 1.9829% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.76% | +3.43% | -71.87% | -96.37% | 55.04L | |
| +0.93% | +6.97% | +59.60% | +69.78% | 5.73TCr | |
| -1.92% | +6.03% | +40.64% | +80.66% | 5.5TCr | |
| -0.46% | -1.29% | +2.86% | +425.15% | 2.32TCr | |
| -2.97% | -2.35% | -22.53% | -15.34% | 2.26TCr | |
| -1.28% | +1.05% | +20.81% | -7.73% | 2.05TCr | |
| -1.34% | +0.51% | +26.03% | -28.68% | 1.76TCr | |
| +0.29% | +2.28% | +34.95% | +548.43% | 1.57TCr | |
| -1.30% | -5.02% | +170.77% | +310.94% | 1.45TCr | |
| -0.50% | -0.98% | +21.43% | +179.36% | 1.39TCr | |
| Average | -0.76% | +1.49% | +28.27% | +146.62% | 2.4TCr | |
| Weighted average by Cap. | -0.82% | +2.10% | +39.17% | +136.86% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.24Cr -1.09Cr -1.01Cr -92.94L -1.75Cr -119.41Cr -1.77Cr -12Cr -4.7Cr -59Cr -4.65Cr -4.55Cr -202.98Cr | -1.33Cr -1.17Cr -1.09Cr -99.69L -1.87Cr -128.08Cr -1.9Cr -13Cr -5.04Cr -63Cr -4.99Cr -4.89Cr -217.72Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/26/24 | $0.3713 | +0.76% | 1,51,226 |
| 23/26/23 | $0.3685 | +1.66% | 5,24,326 |
| 22/26/22 | $0.3625 | -0.44% | 3,03,409 |
| 21/26/21 | $0.3641 | +1.59% | 1,98,583 |
| 20/26/20 | $0.3584 | -0.17% | 3,57,509 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SNGX Stock
Select your edition
All financial news and data tailored to specific country editions
